Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Astec Lifesciences Ltd Performance

Today's Low
1,157.75
arrowIcon
Today's High
1,254.00
52 Wk Low
825.05
arrowIcon
52 Wk High
1,541.65


Open

1229.15

Traded Value (Cr)

7.95 Cr

Prev. Close

1224.3

VWAP

1190.09

Volume

23,156

Face Value

10

Astec Lifesciences Ltd Fundamentals

Market Cap
₹ 2,336 Cr
P/E Ratio (TTM)
0.00
P/B Ratio
6.33
Debt to Equity
1.34
ROE
-12.71 %
EPS (TTM)
0.00
Dividend Yield
0.00%
Book Value
188.32

Click here to know more about Fundamentals

Astec Lifesciences Ltd Financials

Astec Lifesciences Ltd Financials

Astec Lifesciences Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Promoters 66.75 % 66.75 % 66.75 % 66.76 %
Retail 19.62 % 18.19 % 17.91 % 17.75 %
Mutual Funds 7.79 % 8.77 % 9.15 % 9.14 %
Others 4.59 % 5.00 % 4.86 % 4.40 %
FII 1.25 % 1.28 % 1.33 % 1.95 %

Promoters

66.75%

Retail

19.62%

Mutual Funds

7.79%

Others

4.59%

FII

1.25%

Promoters

66.75%

Retail

18.19%

Mutual Funds

8.77%

Others

5.00%

FII

1.28%

Promoters

66.75%

Retail

17.91%

Mutual Funds

9.15%

Others

4.86%

FII

1.33%

Promoters

66.76%

Retail

17.75%

Mutual Funds

9.14%

Others

4.40%

FII

1.95%

Resistance and Support

₹1,214.80

PIVOT

resistance-arrow
Resistance
First Resistance₹1,234.300
Second Resistance₹1,265.050
Third Resistance₹1,284.550
support-arrow
Support
First Resistance₹1,184.050
Second Resistance₹1,164.550
Third Resistance₹1,133.800
RSI38.715
MACD-8.634
ADX56.195
CCI-172.598

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day23,15633,16549.80
Week65,70233,91151.00
1 Month80,39038,51851.48
6 Months23,15611,73250.67

About Astec Lifesciences Ltd

Astec LifeSciences Ltd is a producer of agrochemicals and pharmaceutical intermediates. The company manufactures a wide range of Agrochemical active ingredients and pharmaceutical intermediates. They are having manufacturing facilities located at two locations in Maharashtra, India comprising of three units viz. one unit at Dombivli, Maharashtra and two units at Mahad, Maharashtra (Unit 1 and Unit 2). They are exporting their products to East Asia, Europe, Middle East, and USA. The business of the company comprises of the two major segments, namely Agrochemicals and Pharmaceuticals. Under the Agrochemical segment, the company manufactures active ingredients, intermediates and formulations. Active ingredients are sold to crop protection formulators. Intermediates are supplied to technical grade product manufacturers. Formulations are sold in bulk quantities to companies engaged in retail marketing. Under the Pharmaceutical segment, the company carries out manufacturing of intermediates which are supplied to Active Pharma Ingredients (API) manufacturers. Astec LifeSciences Ltd was incorporated on January 25, 1994 as a private limited company with the name Urshila Traders Pvt Ltd. The company was originally promoted by Reena Bagai and Avita Fernandes. Their shareholding was purchased by Ashok Hiremath and Pratap Garud on February 11, 1994. In August 19, 1994, the name of the company was changed from Urshila Traders Pvt Ltd to Astec Chemicals Pvt Ltd. In August 1994, the company started their first manufacturing unit by acquiring a sick unit in Dombivli, Maharashtra having an installed capacity of 120 MT for the manufacture of Dicap, a pharmaceutical intermediate. In May 2001, they were awarded ISO 9002 Certification by International Standards Certification Pty Limited, Australia. In February 18, 2002, the company entered into an agreement with Behram Chemicals Pvt Ltd with a view to expand their operations for using and operating their manufacturing facilities located at Mahad in Maharashtra. Behram Chemicals Pvt Ltd was engaged in manufacture of chemicals and pesticides with installed capacity of 130 MT. During the year 2003-04, the company expanded the total installed capacity of their units (Dombivli and Mahad) from 250 MT to 500 MT. In the year 2004, they acquired a plot of land located at Mahad, Maharashtra. In May 2005, they set up a new manufacturing facility as an Export Oriented Unit (as Unit 2), which is adjacent to Unit 1 with an installed capacity of 1000 MT. With the commissioning of Unit 2, the company's total installed capacity increased to 1500 MT. In March 2006, the name of the company was changed from Astec Chemicals Pvt Ltd to Astec LifeSciences Pvt Ltd. In April 2006, the company was converted into public limited company and the name was changed to Astec LifeSciences Ltd. During the year 2006-07, the company further expanded their total capacities to 2000 MT. In January 2007, they established Astec Europe in Tournai, Belgium. During the year 2007-08, the company increased the production capacity of Agro & Pharma Intermediates by 500 MT to 2500 MT In April 2007, Behram Chemicals Pvt Ltd became the subsidiary of the company by the acquisition of 65.63% equity by the company vide Share Purchase Agreement. During the year 2008-09, the company increased the production capacity of Agro & Pharma Intermediates by 300 MT to 2800 MT. They established a relationship with a major multinational for supply of one of our products into the global supply chain. During the year 2009-10, the company increased the production capacity of Agro & Pharma Intermediates by 350 MT to 3150 MT. They also introduced new measures to improve EHS performance. In December 2009, the company has bagged orders worth Rs 7 crore from Syngenta India and Nufarm, which are amongst the world's top ten largest agrochemical manufacturing companies. In June 2010, the company entered into a long term mutually exclusive confidential contract to supply an herbicide to a multinational agrochemical major. In August 2010, the company acquired land in MIDC Mahad area admeasuring 40000 sq mtrs with a view to set up additional manufacturing facilities on the new site. In August 27, 2010, the company's Chairman & Managing Director, Ashok V Hiremath was awarded Prestigious 'Business Excellence' Award by the 'Indo-Thai Entrepreneurs Summit' Bangkok, Thailand for his outstanding contribution towards progress and development of Indian Economy and Society. The Company incorporated a 100% wholly owned subsidiary, Astec CropCare Pvt. Ltd. to start the business of trading in agrochemicals and pesticides formulations to sell products. It made investments to increase the capacity of its manufacturing facility and to improvc the quality of products in Mahad. Work was started on construction of new 40000 sq m site at Mahad in Apr' 11. During the year 2012-13, the Company has set-up a new subsidiary namely, Comercializadora Agricola Agroastrachem Cia Ltda in Bagota, Columbia. During period 2015-16, Godrej Agrovet Limited acquired 45.29% of the Equity Share Capital of the Company from its ex-Promoters through an off-market transaction on 12th October, 2015 and consequently, the Company became a subsidiary of Godrej Agrovet Limited with effect from 6th November, 2015. Godrej Agrovet Limited got listed on the Stock Exchanges, viz., BSE Limited and National Stock Exchange of India Limited on 16th October, 2017. During Financial Year 2020-21, Company sold off its entire equity stake in Astec Europe Sprl (a 50.10% subsidiary of Company in Belgium, Europe), in terms of a Share Purchase Agreement executed on 31st August 2020. Accordingly, Astec Europe Sprl ceased to be a subsidiary of Company with effect from 1st September, 2020. During the Financial Year 2021-22, Company also commissioned its new herbicide plant and completed first batch of CMO product. It commercialized two new CMO products and a new production process for an enterprise product. In April 2023, Company inaugurated a state-of-the-art Research & Development (R&D) Centre, named 'Adi Godrej Centre for Chemical Research and Development' in Rabale, Maharashtra.

Managing Director

Founded

1994

NSE Symbol

ASTEC

Astec Lifesciences Ltd Management

NameDesignation
Ashok V HiremathDirector
N B GodrejChairman (Non-Executive)
Balram YadavDirector
Vijay Kashinath KhotIndependent Director
Brahma Nand VyasIndependent Director
Tejashree PradhanCompany Sec. & Compli. Officer
Govindan Ramakrishna RishinaradamangalamIndependent Director
Dhekne Vasant NandkumarIndependent Director
Anjali Rajesh GuptaIndependent Director
Anurag RoyWhole Time Director & CEO
BURJIS GODREJDirector

Astec Lifesciences Ltd News

Astec Lifesciences to conduct AGM
On 29 July 2024
Astec Lifesciences reports consolidated net loss of Rs 0.97 crore in the March 2024 quarter
Sales rise 21.09% to Rs 153.75 crore
Astec Lifesciences to declare Quarterly Result
On 2 May 2024
Astec Lifesciences reports consolidated net loss of Rs 24.33 crore in the December 2023 quarter
Sales decline 56.66% to Rs 50.79 crore
Astec Lifesciences to declare Quarterly Result
On 25 January 2024
Astec Lifesciences reports consolidated net loss of Rs 13.43 crore in the September 2023 quarter
Sales decline 44.54% to Rs 110.79 crore
Astec Lifesciences to discuss results
On 27 October 2023
Astec Lifesciences Ltd leads gainers in 'A' group
Hindustan Construction Company Ltd, NLC India Ltd, Ircon International Ltd and Cressanda Solutions Ltd Partly Paidup are among the other gainers in the BSE's 'A' group today, 09 August 2023.
Astec Lifesciences reports consolidated net loss of Rs 8.19 crore in the June 2023 quarter
Sales decline 22.48% to Rs 142.85 crore
Astec Lifesciences to discuss results
On 27 July 2023

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
PIIND₹ 53,361 Cr
₹ 3,517.15
(-0.07 %)
32.83
UPL₹ 35,012 Cr
₹ 466.45
(-2.39 %)
33.82
BAYERCROP₹ 23,652 Cr
₹ 5,262.95
(-2.60 %)
29.52
SUMICHEM₹ 19,279 Cr
₹ 386.25
(-1.99 %)
58.08
DHANUKA₹ 5,792 Cr
₹ 1,270.85
(-3.00 %)
23.60

Astec Lifesciences Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Astec Lifesciences Ltd shares in BlinkX

The share price of any stock is volatile and changes during the day due to a variety of variables. Astec Lifesciences Ltd's share price is ₹1,194.30 as of May 9, 2024

Astec Lifesciences Ltd's P/E ratio is 0.00 times as of May 9, 2024.

Astec Lifesciences Ltd's most recent financial reports indicate a price-to-book ratio of 6.33, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Astec Lifesciences Ltd's market is 2,336 Cr as on May 9, 2024.

The current financial records of Astec Lifesciences Ltd show a -12.71% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

The 52-week high/low price of a Astec Lifesciences Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Astec Lifesciences Ltd's 52-week high and low as of May 9, 2024 are ₹1254 and ₹1157.75 respectively.

As of the Mar 2024 quarter, the promoter shareholding in Astec Lifesciences Ltd stands at 66.75%. During the same period, Institutional Investors have shown a slight decrease in their holdings, dropping from 1.28% to 1.25%.